Advanced stent coating for drug delivery and in vivo biocompatibility

Journal of Nanoparticle Research

Volumn 15, Issue 10, 2013, Pages

  Liu, Yi ^a   Wang, Wuchen ^a   Acharya, Gayathri ^a   Shim, Yoon Bo ^b   Choe, Eun Sang ^b   Lee, Chi H ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Pusan National University   (South Korea)

Author keywords

Drug eluting stent; EPD technique; Intima formation; MAPK expression; NO donor; Restenosis; Thrombosis

Indexed keywords

ADDITIVES; ARTIFICIAL ORGANS; BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BLOOD VESSELS; CALCIUM COMPOUNDS; COATINGS; COLLAGEN; DISEASES; DRUG PRODUCTS; ELECTROPHORESIS; ENZYMES; HYDROPHOBICITY; NANOPARTICLES; NITRIC OXIDE; PLATELETS; STENTS; TARGETED DRUG DELIVERY;

DRUG-ELUTING STENTS; EPD TECHNIQUE; INTIMA FORMATION; MAPK EXPRESSION; NO DONOR; RESTENOSIS; THROMBOSIS;

CONTROLLED DRUG DELIVERY;

ANTITHROMBOCYTIC AGENT; COLLAGEN; N NITROSOMELATONIN; POLYGLACTIN; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING STENT; DRUG RELEASE; FIBRINOLYSIS; GEL ELECTROPHORESIS; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; IN-STENT RESTENOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; THROMBOCYTE AGGREGATION;

EID: 84883704869     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1962-1     Document Type: Article

References (56)

1. Acharya G, Hopkins R, Lee CH (2011) The effects of advanced polymeric matrix on cardiovascular complications. J Biomed Mater Res A 99(3):485-492
2. Acharya G, Lee Y, Lee CH (2012) Optimization of cardiovascular stent against restenosis: factorial design based statistical analysis of polymer coating conditions. PLoS One 7(8):e43100
3. Ajizian SJ, English BK, Meals EA (1999) Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179(4):939-944. doi: 10.1086/314659 (Pubitemid 29159340)
4. Alvin Koh WC, Rahman MA, Choe ES, Lee DK, Shim YB (2008) A cytochrome c modified-conducting polymer microelectrode for monitoring in vivo changes in nitric oxide. Biosens Bioelectron 23(9):1374-1381. doi: 10.1016/j.bios.2007.12. 008
5. Anderson ME (2005) Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol Ther 106(1):39-55. doi: 10.1016/j.pharmthera.2004.11.002 (Pubitemid 40386719)
6. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, Trovati M (2002) Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. Thromb Res 105(1):71-78 (Pubitemid 34178311)
7. Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J, Carr JM, Armit LJ, Clacher C, Malone L, Kollias G, Arthur JS (2005) Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 25(23):10454-10464 (Pubitemid 41681967)
8. Calvert PA, Bennett MR (2009) Restenosis revisited. Circ Res 104(7):823-825. doi: 10.1161/CIRCRESAHA.109.196345
9. Camenzind E, De Scheerder IK (eds) (2005) Local drug delivery for coronary artery disease: established and emerging applications. Taylor & Francis Group, New York
10. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369(9562):667-678 (Pubitemid 46281313)
11. Dean JL, Brook M, Clark AR, Saklatvala J (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 274(1):264-269 (Pubitemid 29035058)
12. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R (2005) Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 11(1):25-35 (Pubitemid 40194195)
13. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG (2004) The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2:561-573 (Pubitemid 40185679)
14. Forrester JS, Fishbein M, Helfant R, Fagin J (1991) A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 17(3):758-769
15. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME (2003) Six- and twelve-month results from a randomized, double-blind trial on a slow-release Paclitaxel-eluting stent for de novo coronary lesions. Circulation 107:38-42 (Pubitemid 36070930)
16. Holmes DR Jr, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, Fischman D, Goldberg S, Brinker JA, Zeiher AM, Shapiro LM, Willerson J, Davis BR, Ferguson JJ, Popma J, King SB 3rd, Lincoff AM, Tcheng JE, Chan R, Granett JR, Poland M (2002) Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 106(10):1243-1250 (Pubitemid 34988643)
17. Ielasi A, Latib A, Colombo A (2011) Current and Future Drug-eluting Coronary Stent Technology. Expert Rev Cardiovasc Ther 9(4):485-503
18. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA (1981) Mechanism of vascular smooth-muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric-oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218(3):739-749 (Pubitemid 11005147)
19. Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G et al (1995) Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med 1(6):541-545
20. Indolfi C, Cioppa A, Stabile E, Di Lorenzo E, Esposito G, Pisani A, Leccia A, Cavuto L, Stingone AM, Chieffo A, Capozzolo C, Chiariello M (2000) Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol 35(1):214-221 (Pubitemid 30061283)
21. Johnson GV, Bailey CD (2003) The p38 MAP kinase signaling pathway in Alzheimer's disease. Exp Neurol 183(2):263-268 (Pubitemid 37205068)
22. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193-202 (Pubitemid 43929240)
23. Kim SY, Jeoung NH, Oh CJ, Choi YK, Lee HJ, Kim HJ, Kim JY, Hwang JH, Tadi S, Yim YH, Lee KU, Park KG, Huh S, Min KN, Jeong KH, Park MG, Kwak TH, Kweon GR, Inukai K, Shong M, Lee IK (2009) Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Circ Res 104(7):842-850. doi: 10.1161/CIRCRESAHA.108. 189837
24. Kirsch M, de Groot H (2009) N-nitrosomelatonin: synthesis, chemical properties, potential prodrug. J Pineal Res 46:121-127
25. Kluge J, Fusaro F, Mazzotti M, Muhrerb G (2009) Production of PLGA micro- and nanocomposites by supercritical fluid extraction of emulsions: iI Encapsulation of Ketoprofen. J Supercrit Fluids 50:336-343
26. Kunicki TJ (2002) The Influence of Platelet Collagen Receptor Polymorphisms in Hemostasis and Thrombotic Disease. Arterioscler Thromb Vasc Biol 22:14-20 (Pubitemid 34076226)
27. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009-1019 (Pubitemid 46376801)
28. Lee CH, Singla A, Lee Y (2001) Biomedical application of collagen. Int J Pharm 221(1-2):1-22
29. Lee DK, Koh WC, Shim YB, Shim I, Choe ES (2010) Repeated cocaine administration increases nitric oxide efflux in the rat dorsal striatum. Psychopharmacology 208(2):245-256. doi: 10.1007/s00213-009-1724-z
30. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK (1992) A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 86(6 Suppl):III47-III52
31. Liu Y, Acharya G, Lee CH (2011) Effects of dialdehyde starch on calcification of collagen matrix. J Biomed Mater Res A 99(3):485-492
32. Mathew S, Varghese S, Rajammal G, Thomas PC (2007) Dipping characteristics of layered silicates-natural rubber latex nanocomposites. J Appl Polym Sci 104(1):58-65 (Pubitemid 46426312)
33. Mellor H, Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332(Pt 2):281-292 (Pubitemid 28271856)
34. Minamino T, Kitakaze M (2010) ER stress in cardiovascular disease. J Mol Cell Cardiol 48(6):1105-1110. doi: 10.1016/j.yjmcc.2009.10.026
35. Miyauchi K, Kasai T, Yokayama T, Aihara K, Kurata T, Kajimoto K, Okazaki S, Ishiyama H, Daida H (2008) Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model. Circ J 72(5):832-838 (Pubitemid 351716691)
36. Morice M-C, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780 (Pubitemid 34586912)
37. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323 (Pubitemid 37186209)
38. Munzel T, Feil R, Mulsch A, Lohmann SM, Hofmann F, Walter U (2003) Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase [corrected]. Circulation 108(18):2172-2183. doi: 10.1161/01.CIR.0000094403.78467.C3 (Pubitemid 37363031)
39. Nam SH, Nam HY, Joo JR, Baek IS, Park J-S (2007) Curcumin-Loaded PLGA Nanoparticles Coating onto Metal Stent by Electrophoretic Deposition Techniques. Bull Kor Chem Soc 28(3):397-402 (Pubitemid 46465881)
40. Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. Faseb J 9(7):484-496
41. Palaniyandi SS, Sun L, Ferreira JC, Mochly-Rosen D (2009) Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res 82(2):229-239. doi: 10.1093/cvr/cvp001
42. Parenteau-Bareil R, Gauvin R, Berthod F (2010) Collagen-based biomaterials for tissue engineering applications. Materials 3(3):1863-1887
43. Rodriguez AE, Alemparte MR, Vigo CF, Pereira CF, Llaurado C, Russo M, Virmani R, Ambrose JA (2003) Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina single-center study (ORAR Trial). J Invasive Cardiol 15(10):581-584 (Pubitemid 37288544)
44. Santoro SA, Cunningham LW (1977) Collagen-mediated platelet aggregation. J Clin Invest 60:1054-1060
45. Scatena R, Bottoni P, Pontoglio A, Giardina B (2010) Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. Curr Med Chem 17(1):61-73
46. Schini-Kerth VB (1999) Vascular biosynthesis of nitric oxide: effect on hemostasis and fibrinolysis. Transfus Clin Biol 6(6):355-363 (Pubitemid 30021958)
47. Serruys PW, Pd Jaegere, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J (1994) A comparison of balloon-expandable- stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495 (Pubitemid 24256751)
48. Singla A, Lee CH (2003) Inhibition of CEM calcification by the sequential pretreatment with ethanol and EDTA. J Biomed Mater Res A 64A(4):706-713 (Pubitemid 37521267)
49. Spinler SA (2009) Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Am J Manag Care 15:S42-S47
50. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy J-J, Park S-J, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370(9591):15-21
51. Sweeney SE, Firestein GS (2004) Signal transduction in rheumatoid arthritis. Curr Opin Rheumatol 16(3):231-237 (Pubitemid 38530491)
52. Ting J, Lee AS (1988) Human gene encoding the 78,000-dalton glucose-regulated protein and its pseudogene: structure, conservation, and regulation. DNA 7(4):275-286
53. Wang G-R, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME (1998) Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 95(9):4888-4893 (Pubitemid 28208520)
54. 2+/calmodulin-dependent protein kinase II-discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull 28(8):1342-1354 (Pubitemid 41379679)
55. Yoo JW, Lee JS, Lee CH (2010) Characterization of nitric oxide-releasing microparticles for the mucosal delivery. J Biomed Mater Res A 92(4):1233-1243
56. Yoo J-W, Giri N, Lee CH (2011) pH-sensitive Eudragit nanoparticles for mucosal drug delivery. Int J Pharm 403(1-2):262-267